Evidence map›Paper›PMID 17283047›Full record

ArticleMolecular and cellular biology2007

Mitogenic activity and signaling mechanism of 2-(14,15- epoxyeicosatrienoyl)glycerol, a novel cytochrome p450 arachidonate metabolite.

Jianchun Chen, Jian-Kang Chen, John R Falck, Jagadeesh Setti Guthi, Siddam Anjaiah, Jorge H Capdevila, Raymond C Harris

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 34 citations in OpenAlex.

  1. General View of Arachidonic Acid (AA) Metabolism.Reviews of physiology, biochemistry and pharmacology · 2027
    Review
  2. Review
  3. Article
  4. Article
  5. Interaction of the EGF Receptor and the Hippo Pathway in the Diabetic Kidney.Journal of the American Society of Nephrology : JASN · 2016
    Article
  6. Phosphatidylinositol 3-kinase signaling determines kidney size.The Journal of clinical investigation · 2015
    Article
  7. Review
  8. Article
  9. EGFR signaling promotes TGFβ-dependent renal fibrosis.Journal of the American Society of Nephrology : JASN · 2012
    Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
4 · The record

Corrections and comments

  • Erratum issued
    Guthi, Jagadeesh Setti [added]
5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jianchun ChenC-3121 Medical Center North, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Jian-Kang Chen
John R Falck
Jagadeesh Setti Guthi
Siddam Anjaiah
Jorge H Capdevila
Raymond C Harris
The University of Texas Southwestern Medical Center · USVanderbilt Health · US

Funding

TRANSPORT EFFECTS OF ARACHIDONATE METABOLITES IN PERFUSED TUBULEP01DK038226 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BROWN, NANCY J. · 1986 to 2015
$22.1M
The Role of the EGF Receptor in Acute and Chronic Renal InjuryR01DK051265 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RAYMOND C. HARRIS, Mingzhi Zhang · 1997 to 2026
$10.1M
NIDDK NIH HHS DK38226NIDDK NIH HHS DK51265NIDDK NIH HHS P01 DK038226NIDDK NIH HHS R01 DK051265
6 · The paper itself

Abstract

Arachidonic acid is an essential constituent of cell membranes that is esterified to the sn-2 position of glycerophospholipids and is released from selected phospholipid pools by tightly regulated phospholipase cleavage. Metabolism of the released arachidonic acid by the cytochrome P450 enzyme system (cP450) generates biologically active compounds, including epoxyeicosatrienoic acids (EETs) and hydroxyeicosatetraenoic acids. Here we report that 2-(14,15-epoxyeicosatrienoyl)glycerol (2-14,15-EG), a novel cP450 arachidonate metabolite produced in the kidney, is a potent mitogen for renal proximal tubule cells. This effect is mediated by activation of tumor necrosis factor alpha-converting enzyme (ADAM17), which cleaves membrane-bound transforming growth factor alpha (proTGF-alpha) and releases soluble TGF-alpha as a ligand that binds and activates epidermal growth factor receptor (EGFR). The present studies additionally demonstrate that the structurally related 14,15-EET stimulates release of soluble heparin-binding EGF-like growth factor as an EGFR ligand by activation of ADAM9, another member of the ADAM family. Thus, in addition to the characterization of 2-14,15-EG's mitogenic activity and signaling mechanism, our study provides the first example that two structurally related biologically active lipid mediators can activate different metalloproteinases and release different EGFR ligands in the same cell type to activate EGFR and stimulate cell proliferation.

Indexed as

8,11,14-Eicosatrienoic AcidADAM17 ProteinADAM ProteinsAnimalsArachidonic AcidCell LineCytochrome P-450 Enzyme SystemDown-RegulationEnzyme ActivationEpidermal Growth FactorEpithelial CellsErbB ReceptorsExtracellular Signal-Regulated MAP KinasesGene Expression Regulation, EnzymologicGlycerolHeparin-binding EGF-like Growth Factor14,15-epoxy-5,8,11-eicosatrienoic acid2-(14,15-epoxyeicosatrienoyl)glycerol8,11,14-Eicosatrienoic AcidADAM17 ProteinADAM ProteinsArachidonic AcidCytochrome P-450 Enzyme SystemEpidermal Growth FactorErbB ReceptorsExtracellular Signal-Regulated MAP KinasesGlycerolHeparin-binding EGF-like Growth FactorIntercellular Signaling Peptides and ProteinsMembrane ProteinsMitogensMonoglyceridesReceptors, CannabinoidRNA, Small InterferingTransforming Growth Factor alpha

Identifiers

PMID17283047
PMCPMC1899952
OpenAlexW2168077068

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.